Sara Vesely to Evidence-Based Medicine
This is a "connection" page, showing publications Sara Vesely has written about Evidence-Based Medicine.
Connection Strength
1.030
-
Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb; 141(2 Suppl):e737S-e801S.
Score: 0.364
-
How can we provide the best care for our patients with immune thrombocytopenic pupura? Mayo Clin Proc. 2004 Apr; 79(4):456-7.
Score: 0.211
-
Development and application of health outcome descriptors facilitated decision-making in the production of practice guidelines. J Clin Epidemiol. 2021 10; 138:115-127.
Score: 0.173
-
American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism. Blood Adv. 2018 11 27; 2(22):3292-3316.
Score: 0.146
-
GRADE notes: How to use GRADE when there is "no" evidence? A case study of the expert evidence approach. J Clin Epidemiol. 2021 09; 137:231-235.
Score: 0.043
-
Methodology for the American Society of Hematology VTE guidelines: current best practice, innovations, and experiences. Blood Adv. 2020 05 26; 4(10):2351-2365.
Score: 0.040
-
The role of rituximab in the management of patients with acquired thrombotic thrombocytopenic purpura. Blood. 2015 Mar 05; 125(10):1526-31.
Score: 0.028
-
Conflicts of interest and clinical recommendations: comparison of two concurrent clinical practice guidelines for primary immune thrombocytopenia developed by different methods. Am J Med Qual. 2014 Jan-Feb; 29(1):53-60.
Score: 0.025